Senior Medical Director, Hematology – Lymphoma (Lacutamab)
About the role
The Senior Medical Director, Hematology – Lymphoma leads the medical strategy for the Cutaneous T-Cell Lymphoma (CTCL) disease area within Hematology Medical Affairs, driving both brand medical strategy and external engagement with Opinion Leaders, community physicians, medical societies, and top accounts. This role offers an experienced Medical Director the opportunity to lead medical strategy for a complex hematologic malignancy, engaging across the hematology-oncology, dermatology, and dermato-oncology communities while shaping how Sobi supports the CTCL patient and provider community. The Senior Medical Director will also lead launch preparatory efforts for lacutamab, a humanized monoclonal antibody immunotherapy targeting KIR3DL2. The Senior Medical Director serves as the lead medical voice for lymphoma and lacutamab, conceptualizing and implementing the US medical strategy for the disease area. This person reports to the Vice President, Head of Hematology Medical Affairs, partners closely with Field Medical to engage HCPs, medical organizations, payers, and patient advocacy groups, and acts as the medical lead on the Brand Team.
Responsibilities
- Serve as the lead medical strategist for CTCL and lacutamab, providing strategic leadership for medical strategy, brand-aligned tactics, and external clinician engagement across academic, community, and multidisciplinary care settings.
- Own launch readiness for lacutam